Patent 11666378 was granted and assigned to Neurent Medical on June, 2023 by the United States Patent and Trademark Office.
The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.